Research conducted at Cornell University reveals that early exposure to allergens significantly reduces the likelihood of allergic reactions later in life in Icelandic horses. The study,...
The European Medicines Agency (EMA) has moved forward with a positive recommendation for Gobivaz®, a proposed biosimilar to Simponi® (golimumab), developed by Alvotech, a biotechnology firm...
